Christopher Heery
Chief Tech/Sci/R&D Officer bei ARCELLX, INC.
Vermögen: 621 638 $ am 31.03.2024
Profil
Christopher R.
Heery is currently the Chief Medical Officer at Arcellx, Inc. Prior to this, he was the Chief Medical Officer at Precision BioSciences, Inc. from 2019 to 2021.
He also held the position of Chief Medical Officer at Bavarian Nordic A and was the Head-Clinical Trials at the National Cancer Institute.
Heery received his undergraduate degree from Duke University and his doctorate from Brody School of Medicine in 2006.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARCELLX, INC.
0,02% | 01.04.2024 | 8 938 ( 0,02% ) | 621 638 $ | 31.03.2024 |
Aktive Positionen von Christopher Heery
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCELLX, INC. | Chief Tech/Sci/R&D Officer | 01.04.2021 |
Ehemalige bekannte Positionen von Christopher Heery
| Unternehmen | Position | Ende |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 23.04.2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Christopher Heery
| Duke University | Undergraduate Degree |
| Brody School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| BAVARIAN NORDIC A/S | Health Technology |
| ARCELLX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
